Company Profiles

driven by the PitchBook Platform

Angiocrine Bioscience

Description

Developer of curative cellular therapies designed to treat indications in regenerative medicine and hematopoietic stem cell gene therapy. The company's curative cellular therapies including its E-CEL technology comprises of cultured endothelial cells, genetically modified via insertion of the adenovirus E4ORF1 gene, enabling physicians to improvise their treatment and therapeutic procedures.

2012

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$4M

Latest Deal Amount

$4M

Total Amount Raised

Description

Developer of curative cellular therapies designed to treat indications in regenerative medicine and hematopoietic stem cell gene therapy. The company's curative cellular therapies including its E-CEL technology comprises of cultured endothelial cells, genetically modified via insertion of the adenovirus E4ORF1 gene, enabling physicians to improvise their treatment and therapeutic procedures.

Website:

www.angiocrinebioscience.com

Ownership Status

Privately Held (backing)

Financing Status

Angel-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Therapeutic Devices

Primary Office

11575 Sorrento Valley Road Suite 217 San Diego, CA 92121United States +1 (877) 784-8496
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Angiocrine Bioscience's full profile, request a free trial.

Angiocrine Bioscience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Angiocrine Bioscience Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Angiocrine Bioscience Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Paul Finnegan MDChief Executive Officer & Board Member
John KlackingChief Financial Officer, Board Member & Co-Founder
Geoffrey Davis Ph.DPresident, Chief Scientific Officer, Board Member & Co-Founder
Daniel Nolan Ph.DDirector, Research
Jeffrey Port MDCo-Founder & Chairman
Paul Finnegan MD Chief Executive Officer & Board Member
John Klacking Chief Financial Officer, Board Member & Co-Founder
Geoffrey Davis Ph.D President, Chief Scientific Officer, Board Member & Co-Founder
Daniel Nolan Ph.D Director, Research
Jeffrey Port MD Co-Founder & Chairman

Angiocrine Bioscience Board Members (4)

NameRepresentingRoleSinceContact
Info
Andrew BrooksSelfBoard Member000 0000
Geoffrey Davis Ph.DAngiocrine BiosciencePresident, Chief Scientific Officer, Board Member & Co-Founder000 0000
Jeffrey Port MDAngiocrine BioscienceCo-Founder & Chairman000 0000
Paul Finnegan MDAngiocrine BioscienceChief Executive Officer & Board Member000 0000
Andrew Brooks Board Member Self
Geoffrey Davis Ph.D President, Chief Scientific Officer, Board Member & Co-Founder Angiocrine Bioscience
Jeffrey Port MD Co-Founder & Chairman Angiocrine Bioscience
Paul Finnegan MD Chief Executive Officer & Board Member Angiocrine Bioscience
Request full access to PitchBook